Watch this must-see YouTube video about Algernon Pharmaceutical (CSE: AGN)'s clinical trial of DMT for stroke.
This is so much bigger than anything Small Pharma (TSXV: DMT) is doing, yet DMT gained by 26% today and has gained by 162.5% over the past month!
DMT is now worth CAD$100 million+ in market cap when AGN is a much higher quality company!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from AGN of US$100,000 cash for a twelve-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.